Benzaclin and Ulcerative colitis - a phase IV clinical study of FDA data

Summary:

Ulcerative colitis is reported as a side effect among people who take Benzaclin (benzoyl peroxide; clindamycin phosphate), especially for people who are male, 30-39 old, have been taking the drug for < 1 month also take Accutane, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Ulcerative colitis when taking Benzaclin. It is created by eHealthMe based on reports of 447 people who have side effects when taking Benzaclin from the FDA, and is updated regularly.

What is Benzaclin?

Benzaclin has active ingredients of benzoyl peroxide; clindamycin phosphate. It is often used in acne. eHealthMe is studying from 477 Benzaclin users. Check the latest studies of Benzaclin.

What is Ulcerative colitis?

Ulcerative colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine) is found to be associated with 1,199 drugs and 2,052 conditions by eHealthMe. Check the latest studies of Ulcerative colitis.

On Jul, 19, 2026

447 people reported to have side effects when taking Benzaclin.
Among them, 33 people (7.38%) have Ulcerative colitis.

Could Benzaclin cause Ulcerative colitis?

Among these 33 people:

How long have people been on Benzaclin when they have Ulcerative colitis? *

What is the gender of people who have Ulcerative colitis when taking Benzaclin? *

female: 45.45 %
male: 54.55 %

What is the age of people who have Ulcerative colitis when taking Benzaclin? *

What are other drugs people take besides Benzaclin? *

What are other side effects people have besides Ulcerative colitis? *

Inflammatory Bowel Disease: 18 people, 54.55%
Intestinal Obstruction: 18 people, 54.55%
Intestinal Haemorrhage (bleeding from intestine): 18 people, 54.55%
Weight Decreased: 18 people, 54.55%
Leukocytosis (increased white blood cells): 16 people, 48.48%
Anaemia (lack of blood): 15 people, 45.45%
Oedema Peripheral (superficial swelling): 14 people, 42.42%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 14 people, 42.42%
Nausea And Vomiting: 13 people, 39.39%
Rectal Haemorrhage (bleeding from anus): 13 people, 39.39%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 2 people, 6.06%

* Approximation only. Some reports may have incomplete information.

Do you take Benzaclin and have Ulcerative colitis?

- Check whether Ulcerative colitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Benzaclin:

Benzaclin (477 reports)

Ulcerative colitis treatments and more:

Ulcerative colitis (188,235 reports)

How severe was Ulcerative colitis and when was it recovered:

Ulcerative colitis in Benzaclin

Expand to all the drugs that have ingredients of benzoyl peroxide; clindamycin phosphate:

Ulcerative colitis and drugs with ingredients of benzoyl peroxide; clindamycin phosphate

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Benzaclin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Ulcerative colitis:

Ulcerative colitis (1,199 drugs)

Browse all the conditions that are associated with Ulcerative colitis:

Ulcerative colitis (2,052 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on benzoyl peroxide; clindamycin phosphate (the active ingredients of Benzaclin) and Benzaclin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.